Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aytu BioPharma, Inc. (AYTU) vs Incannex Healthcare Inc. (IXHL)

Aytu BioPharma, Inc. and Incannex Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Incannex Healthcare Inc. is the larger, with a market value of $40.7M against $25.1M — 1.6× the size. Incannex Healthcare Inc. has the higher net margin (0.00% vs −24.8%) and the lower return on invested capital (−2,022.1% vs −20.0%). Across the 17 metrics below, Aytu BioPharma, Inc. leads on 10 and Incannex Healthcare Inc. on 7.

Valuation

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.48 26.27 2.25
P/B 0.78 0.54 1.90
Price to free cash flow 8.53 n/m 16.54
EV/EBITDA n/m 1.18 12.29
EV/Sales 0.32 (19.01) 2.56
Earnings yield (51.16%) (514.59%) (2.99%)
Free cash flow yield 11.72% (43.26%) 0.00%

Profitability

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
Gross margin 63.95% (0.10%) 53.94%
Operating margin (14.44%) 0.00% 0.00%
Net margin (24.76%) 0.00% 0.00%
Free cash flow margin 5.62% 0.00% 0.00%
Return on equity (52.55%) (117.17%) (0.40%)
Return on assets (12.44%) (100.36%) (3.32%)
Return on invested capital (19.99%) (2,022.08%) 0.00%

Growth

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (13.27%) — 10.01%
EPS growth (last fiscal year) 46.44% (17.39%) —
Revenue growth, 5-year CAGR (2.59%) (29.64%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
Debt to equity 0.48 0.00 0.05
Current ratio 1.13 41.56 2.31
Net debt to EBITDA 2.17 0.64 0.85

Dividend

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
Market cap 25.10m 40.66m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack